Latest Breaking News On - 3 nrsn il0011809592 - Page 1 : comparemela.com

NeuroSense Therapeutics Receives $4 Million Through Warrant Exercises - Warrants exercised at $6 per share - Extends cash runway through Q3 2023 . | March 25, 2022

Cambridge
Cambridgeshire
United-kingdom
Linkedin
Twitter
European-medicines-agency
Prnewswire-neurosense-therapeutics-ltd
Nasdaq
Neurosense-therapeutics-ltd
Neurosense-therapeutics-receives
Through-warrant